Investigating biological traces of traumatic stress in changing societies: challenges and directions from the ESTSS Task Force on Neurobiology by Thomaes, Kathleen et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Investigating biological traces of traumatic stress in changing societies:
challenges and directions from the ESTSS Task Force on Neurobiology
Thomaes, Kathleen ; de Kloet, Carien ; Wilker, Sarah ; El-Hage, Wissam ; Schäfer, Ingo ; Kleim, Birgit
; Schmahl, Christian ; van Zuiden, Mirjam
Abstract: Traumatic stress can have severe consequences for both mental and physical health. Further-
more, both psychological and biological traces of trauma increase as a function of accumulating traumatic
experiences. Neurobiological research may aid in limiting the impact of traumatic stress, by leading to ad-
vances in preventive and treatment interventions. To promote the possibility for clinical implementation
of novel research findings, this brief review describes timely conceptual and methodological challenges
and directions in neurobiological trauma research on behalf of the Task Force ”Neurobiology of Traumatic
Stress” of the European Society for Traumatic Stress Studies (ESTSS). The most important conceptual
challenges are the heterogeneity of disorders and existence of subtypes across diagnostic categories: dif-
ferential latent profiles and trajectories regarding symptom expression and neural correlates are being
unraveled; however, similar latent classes’ approaches for treatment response and neurobiological data re-
main scarce thus far. The key to improving the efficacy of currently available preventive interventions and
treatments for trauma-related disorders lies in a better understanding and characterization of individual
differences in response to trauma and interventions. This could lead to personalized treatment strategies
for trauma-related disorders, based on objective information indicating whether individuals are expected
to benefit from them. The most important methodological challenge identified here is the need for large
consortia and meta-analyses or, rather, mega-analyses on existent data as a first step. In addition, large
multicenter studies, combining novel methods for repeated sampling with more advanced statistical mod-
eling techniques, such as machine learning, should aim to translate identified disease mechanisms into
molecular blood-based biomarker combinations to predict disorder vulnerability and treatment responses.
DOI: https://doi.org/10.3402/ejpt.v7.29453
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-176711
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Thomaes, Kathleen; de Kloet, Carien; Wilker, Sarah; El-Hage, Wissam; Schäfer, Ingo; Kleim, Birgit;
Schmahl, Christian; van Zuiden, Mirjam (2016). Investigating biological traces of traumatic stress in
changing societies: challenges and directions from the ESTSS Task Force on Neurobiology. European
Journal of Psychotraumatology, 7:29453.
DOI: https://doi.org/10.3402/ejpt.v7.29453
2
PROCEEDINGS PAPER
Investigating biological traces of traumatic stress
in changing societies: challenges and directions from
the ESTSS Task Force on Neurobiology
Kathleen Thomaes1*, Carien de Kloet2, Sarah Wilker3, Wissam El-Hage4,
Ingo Scha¨fer5, Birgit Kleim6,7, Christian Schmahl8 and Mirjam van Zuiden9
1GGZ inGeest/Department of Psychiatry & Anatomy and neurosciences, VU University Medical Center,
Amsterdam, The Netherlands; 2Arq Psychotrauma Expert Group, Foundation Centrum ’45, Oegstgeest,
The Netherlands; 3Department of Clinical and Biological Psychology, Ulm University, Ulm, Germany;
4Department of Psychiatry, CHRU de Tours, Inserm U930, University of Tours, Tours, France; 5Department of
Psychiatry, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany;
6Department of Psychology, University of Zurich, Zu¨rich, Switzerland; 7Department of Psychiatry,
Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, Zurich, Switzerland;
8Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Medical
Faculty Mannheim, Heidelberg University, Heidelberg, Germany; 9Department of Psychiatry, Academic
Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Traumatic stress can have severe consequences for both mental and physical health. Furthermore, both
psychological and biological traces of trauma increase as a function of accumulating traumatic experiences.
Neurobiological research may aid in limiting the impact of traumatic stress, by leading to advances in pre-
ventive and treatment interventions. To promote the possibility for clinical implementation of novel research
findings, this brief review describes timely conceptual and methodological challenges and directions in
neurobiological trauma research on behalf of the Task Force ‘‘Neurobiology of Traumatic Stress’’ of the
European Society for Traumatic Stress Studies (ESTSS). The most important conceptual challenges are the
heterogeneity of disorders and existence of subtypes across diagnostic categories: differential latent profiles
and trajectories regarding symptom expression and neural correlates are being unraveled; however, similar
latent classes’ approaches for treatment response and neurobiological data remain scarce thus far. The key to
improving the efficacy of currently available preventive interventions and treatments for trauma-related
disorders lies in a better understanding and characterization of individual differences in response to trauma
and interventions. This could lead to personalized treatment strategies for trauma-related disorders, based on
objective information indicating whether individuals are expected to benefit from them. The most important
methodological challenge identified here is the need for large consortia and meta-analyses or, rather, mega-
analyses on existent data as a first step. In addition, large multicenter studies, combining novel methods for
repeated sampling with more advanced statistical modeling techniques, such as machine learning, should aim
to translate identified disease mechanisms into molecular blood-based biomarker combinations to predict
disorder vulnerability and treatment responses.
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n the early 2000s, over 60% of Western European
adults reported at least one potentially traumatic
experience, ranging from accidents and disasters to
interpersonal violence and war exposure (Darves-Bornoz
et al., 2008). Since then, war crimes and terror against
civilians have been persistent problems. Current European
examples are the East-Ukraine Crisis, including the
shooting of passenger flight MH17, and the terrorist
attacks on November 13, 2015, in Paris, France. Even
more, ongoing conflicts outside Europe lead to a high
number of trauma survivors seeking asylum in Europe. As
of November 2015, an unprecedented total of over 500,000
refugees reached Europe by Sea. Accordingly, traumatic
experiences in and outside of Europe will likely have long
lasting influences on European society. A central challenge
will be the (secondary) prevention and treatment of the
adverse consequences of these traumatic experiences.
Whilemosttraumatizedindividualsareresilient (Bonanno,
Westphal, & Mancini, 2011), a significant subset develops
trauma-related disorders, including posttraumatic stress
disorder (PTSD) (Darves-Bornoz et al., 2008) and dis-
sociative disorders (Teicher & Samson, 2013), and other
psychiatric disorders such as depressive (North et al., 2015)
and substance abuse disorders (Brady & Back, 2012). In
the context of refugees, who often survived repeated
trauma exposure, it is important to note that the risk
for PTSD increases with the number of traumatic experi-
ences (Kolassa, Kolassa, Ertl, Papassotiropoulos, & De
Quervain, 2010). Furthermore, the probability of sponta-
neous remission from PTSD decreases with increasing
traumatic load (Kolassa et al., 2010). The aim of this re-
view paper is to outline current challenges in the field
of neurobiological trauma research, as well as promising
research directions that may help reducing the negative
impact of trauma and may promote clinical implementa-
tion of novel research findings. For this purpose, we pro-
vide a concise overview of known biological consequences
of trauma and PTSD; lines of research that may reduce the
negative impact of trauma by improved prevention or
treatment; conceptual and methodological challenges as-
sociated with these lines of research; and how the ‘‘ESTSS
Task Force on Neurobiology of Traumatic Stress’’ aims to
address some of the raised issues.
Adverse biological consequences
Trauma and subsequent trauma-related disorders not only
affect mental health but also have adverse consequences
on the biological level. Both trauma and trauma-related
disorders are associated with increased risk for age-related
physical diseases (De Hert et al., 2011) and increased
mortality (Chesney, Goodwin, & Fazel, 2014). Further-
more, the building block effect of traumatic load (Schauer
et al., 2003) is also reflected in a dose-dependent increased
risk for age-related physical diseases (Felitti et al., 1998).
Although the exact molecular mechanisms under-
lying this elevated risk and their interaction with lifestyle
factors warrant further research, a multitude of studies
have shown that both trauma exposure and trauma-related
disorders are associated with dysfunctioning of numerous
biological systems (Schmidt, Kaltwasser, & Wotjak, 2013).
In addition, initial evidence indicates a cumulative effect of
trauma load and PTSD symptom severity, as reflected by
findings indicating premature aging of, for example, the
immune system (Sommershof et al., 2009; Morath et al.,
2014), and telomere length (Ladwig et al., 2013) as a
function of traumatic load and PTSD severity. However,
recent research also has shown that dysfunctioning in
several biological systems precedes the development of
trauma-related disorders (Schmidt et al., 2013). These
biological vulnerabilities likely (partially) result from
epigenetic changes due to prior traumatic experiences of
the individual (Heinzelmann & Gill, 2013) or previous
generations (Yehuda et al., 2014).
Neurobiological research to limit the impact
of trauma
To limit the impact of traumatic stress, it is pivotal to
increase our knowledge on the neurobiological mechan-
isms preceding development of PTSD and other trauma-
related disorders. Further unraveling peri- and posttrauma
neurobiological (and related cognitive) mechanisms un-
derlying development of trauma-related disorders may
improve prevention in two ways. First, identification of
risk biomarkers may aid in early identification of indivi-
duals at risk. This way, early interventions may be targeted
toward at-risk individuals, thereby not interfering with
normative adaptive recovery in most trauma-exposed.
Second, identification of these mechanisms may inform
development or improvement of preventive interventions
(Van Zuiden et al., 2013). Several promising preventive
interventions for PTSD have recently been developed. Two
of the most promising interventions to be administered
early upon trauma are prolonged exposure and single or
repeated administration of hydrocortisone (for review,
see Sijbrandij et al., 2015). However, none of these
interventions have been implemented yet because large-
scale replication and feasibility studies still need to be
performed. Therefore, it remains important to develop
additional preventive strategies and investigate who may
benefit most from such interventions.
Once trauma-related disorders have become manifest,
a large subset of patients seeking treatment does not
adequately respond to the existing treatments (Bisson,
Roberts, Andrew, Cooper, & Lewis, 2013). Neurobiological
research on processes associated with successful recovery is
essential in the development or improvement of effective
treatment strategies. The identification of mechanisms
underlying successful recovery may augment the efficacy
of currently existing evidence-based psychotherapeutic
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interventions, by providing the opportunity to add
neurobiological-informed agents that target processes
found to be pivotal for successful treatment and recovery.
Such strategies include pharmacological enhancement
of psychotherapy (for review, see Dunlop, Mansson, &
Gerardi, 2012) and combining psychotherapy with
brain stimulation and neuromodulation techniques (for
review, see Marin, Camprodon, Dougherty, & Milad, 2014).
Currently, this field is still in its infancy, and only few
neurobiological augmentation strategies have been in-
vestigated yet. Regarding medication-enhanced psychother-
apy, addition of D-cycloserine, hydrocortisone, MDMA, and
propranolol in addition to exposure therapy have been the
most studied interventions. Seeing the promising effects in
anxiety disorders, expectations regarding their efficacy in
enhancing treatmentresponse were quite high. However, the
current evidence for the efficacy of these agents is incon-
clusive, and larger RCT’s are necessary to investigate whether
these agents indeed hold promise (for reviews, see De Kleine,
Rothbaum, Van Minnen, 2013, Ori et al., 2015). Also, the
safety (for e.g., MDMA) and potential interactions with
commonly used selective serotonin re-uptake inhibitors
(SSRIs) and alcohol (for e.g., propranolol) should be
investigated (De Kleine et al., 2013). Elucidation of neuro-
biological mechanisms of PTSD recovery has also spurred
research on other potentially promising agents for medica-
tion-enhanced psychotherapy. For example, neural effects of
intranasal oxytocin administration in PTSD patients indicate
that this may also be a promising augmentation strategy, but
this needs to be investigated within a clinical setting (Koch
et al., 2015). Importantly, specific treatment interventions
may only work for certain subgroups of patients because
trauma-related disorders show large heterogeneity and
individual treatment responses vary accordingly. Therefore,
treatment response may be improved by identifying biomar-
kers to predict treatment response, for this could eventually
lead to algorithms for personalized treatment. Several
biological parameters have already been found to predict
PTSD treatment response, for example: cytosine methyla-
tion; GR gene expression; 5-HTTLPR genotype; BDNF in
serum; anterior cingulate cortex (ACC) volume and ACC
and amygdala activity (for review, see Thomaes et al., 2014;
Yehuda et al., 2013). Other parameters were found to change
in parallel with recovery, for example: methylation of the
FKBP5 gene, cortisol and DHEA levels, and ACC, insula
and amygdala activity (Ibid). However, studies investigating
such biomarkers were generally small, and none of these po-
tential biomarkers have yet reached the threshold of a specific
and clinically usable biomarker (Lehrner & Yehuda, 2014).
Over the past decades, much knowledge on neurobio-
logical correlates of trauma and trauma-related disorders
has been collected in cross-sectional studies comparing
affected individuals to control groups, of which the most
consistent conclusions are smaller hippocampal volume,
increased amygdala activity to threat, sympathic nervous
system hyperactivity and glucocorticoid receptor dysregu-
lation in PTSD patients (for review, see Schmidt et al.,
2013), although findings are majorly impacted by whether
controls were trauma-exposed or not. More recently, pro-
spective and longitudinal research in individuals at risk for
trauma exposure, recently trauma-exposed individuals, and
patients commencing treatment has also been initiated, as
well as translational approaches integrating experimental
rodent and human in vivo and in vitro studies and clinical
trials (for review, see Schmidt et al., 2013). While these are
promising novel directions, until now translation of findings
into clinical practice remains limited. To achieve this, several
timely challenges have to be overcome, of which we discuss
the most important ones below.
Conceptual challenges and directions
Driven by the classification of psychiatric disorders, much
previous research on trauma-related disorders focused
on one disorder at a time, while considering all patients
as a homogenous sample. However, from a within-disorder
perspective, it has become increasingly apparent that dis-
orders are heterogeneous, and that subtypes regarding
symptom expression and neurobiological correlates exist.
This is supported by recent studies that identified differ-
ential latent profiles and trajectories for subsets of patients
(e.g., Nugent, Koenen, & Bradley, 2012). However, similar
latent class approaches for treatment response and
neurobiological data remain scarce thus far (an exception
is e.g., Galatzer-Levy et al., 2013). Also, moderating effects
of essential patient characteristics, such as sex (including
menstrual phase during neurobiological assessments, trauma
exposure and/or treatment sessions), age, ethnicity, and
developmental timing of trauma exposure on neurobi-
ological mechanisms underlying development, recovery and
treatment-mechanisms have only sparsely been addressed.
From a between-disorder perspective, the overlap in
symptoms and vast comorbidity between disorders, as
well as observed similar neurobiological correlates (e.g.,
short allele of serotonin transporter length polymorphism
(Kuzelova, Ptacek, & Macek, 2010)), demonstrate that
psychiatric disorders should not be regarded in isolation.
Furthermore, the range of psychiatric disorders for which
the onset and course is impacted by trauma exposure,
especially when experienced early in life, is much broader
than those formally acknowledged as trauma-related,
including, for example, personality (Zanarini et al., 1997),
depressive (North et al., 2015) psychotic (for review, see
Varese et al., 2012), and bipolar disorders (for review, see
Etain, Henry, Belivier, Mathieu, & Leboyer, 2008), stres-
sing that research on neurobiological aspects of trauma
should broaden its scope.
The key to improving the efficacy of currently avail-
able preventive interventions and treatments for trauma-
related disorders lies in a better understanding and
characterization of individual differences in response to
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trauma and interventions. This could lead to personalized
treatment strategies for trauma-related disorders, based on
objective information indicating whether individuals are
expected to benefit from them. From both within- and
between-disorder viewpoints, it can be argued that
future studies should incorporate cross-disorder, trans-
diagnostic, domain-oriented approaches at both the
symptom and biological levels, as is also posited in the
US National Institutes of Mental Health Research domain
criteria (RDOC) framework (Insel et al., 2010). Also,
whether findings in one patient population can be general-
ized toward other populations should receive more em-
phasis in future research, to ensure adequate translation of
findings into effective clinical practice.
Methodological challenges and directions
A large proportion of previous neurobiological studies
had relatively small sample sizes, raising concerns about
generalizability and validity of their results. Therefore,
we need large consortia and meta-analyses or, rather,
mega-analyses on existent data, such as the ENIGMA
(Thompson et al., 2014) and Psychiatric Genomics Con-
sortium (Psychiatric GWAS Consortium Steering Com-
mittee, 2009), as a first step. In addition, large multicenter
studies, combining novel methods for repeated sampling,
such as ecological momentary assessment via smartphones,
with in-depth multilevel biological assessment may further
advance the field. Current studies are often limited by
focus on single biomarkers or other predictors as abasis for
intervention allocation. However, we need more advanced
statistical modeling techniques, such as machine learning
(Sato et al., 2015), and should aim to translate identi-
fied disease mechanisms into molecular blood-based bio-
marker combinations (e.g., Chan et al., 2014) to combine
different biological variables to predict disorder vulner-
ability and treatment responses. At the same time, the need
for innovative pilot studies in single centers to develop
and test novel hypotheses remains.
Replicability is another important point to be addressed
within the field. Therefore, we need more transparent
descriptions of analyses and data repositories, especially
in neuroimaging studies where sample sizes are usually
small and options of statistical analyses are large. Further-
more, with respect to replicability but also to data pooling,
similar methodologies are needed to be able to compare
results of individual studies, both regarding protocols used
for collecting biological data and regarding questionnaires
or interviews used for phenotypic assessment and assess-
ment of trauma exposure.
In addition, non-clinical laboratory traumatic stress
models may result in fundamental knowledge on the
mechanisms underlying development of trauma-related
disorders and on risk factors that may influence vulner-
ability upon trauma exposure. Such models, including the
commonly used and well-validated trauma film paradigm
that reliably induces mildly distressing intrusive re-
experiencing (Holmes & Bourne, 2008), allow for detailed
investigation of the exact temporal course of neurobio-
logical responses during analogue traumatic stress, and
how individual variability in neurobiological functio-
ning relates to symptom development. This is important
because such detailed assessment during trauma exposure
is not feasible in clinical settings. Combining research in
traumatized individuals with and without subsequent
psychopathology with such experimental traumatic stress
models (Ehring, Kleim, & Ehlers, 2011), but also with
animal traumatic stress models and in vitro laboratory
models may readily advance our fundamental knowledge
on traumatic stress.
Conclusions
As traumatic experiences increase the risk to suffer from
psychiatric disorders, a central challenge for the European
society is to timely prevent and treat trauma-related
disorders. The exact neurobiological mechanisms under-
lying development and recovery of these disorders are as
of yet not fully understood. To be able to limit the impact
of traumatic stress on both an individual and societal
level, it is pivotal to increase our knowledge of these neuro-
biological mechanisms.
In this review, we have described several conceptual and
methodological challenges and directions for the research
field. Within the ESTSS Task Force on ‘‘Neurobiology
of Traumatic Stress,’’ we strive to address several of these
issues in the following ways:
. Promote discussion and exchange of methodology
between affiliated researchers
. Encourage publication of standardized assessment
protocols and inform task force members about
newly published protocols, via website and work-
shops or symposia on conferences on traumatic stress
. Provide a safe platform for researchers to investigate
novel potential collaborations, including additional
centers for multicenter trials, or novel avenues to test
hypotheses in translational research
. As a first step in establishing novel collaborations,
investigate possibilities to combine already collected
neurobiological data from different research groups
(e.g., mega-analysis and meta-analysis), specifically
on the HPA axis
It is our hope and expectation that adequately addres-
sing and overcoming the challenges highlighted in this
review will promote the much needed development and
implementation of novel neurobiological-informed pre-
ventive and personalized treatment strategies for trauma-
related disorders.
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